IBB ETF Research - iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology (ibb)

Last Updated by Anonymous | Update This Page Now

►Summary | Add New ETF | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 104

Threats + Weaknesses = 71

When strengths & opportunities substantially exceed threats & weaknesses an investment in the ibb ETF has great long term potential.

ETF Description Update

iShares Nasdaq Biotechnology (IBB) Description: IBB is an exchange trading fund (ETF), which is a security that tracks a basket of assets, but trades like a stock. IBB exchange trading fund (ETF) tracks the Biotechnology; this equity index contains nsdq listed companies classified as either biotechnology or pharmaceuticals companies. iShares Nasdaq Biotechnology (IBB) falls under the Health & Biotech Equities category. IBB's dividend yield is roughly 0%, it has an expense ratio of 0.48%, and is in the equity ETF asset class. iShares Nasdaq Biotechnology (IBB) focuses its investments in the U.S. region of the world. IBB does not use leverage and IBB's performance is meant to match its benchmark. The IBB ETF belongs to the Health & Biotech sector. An investor can find IBB's top holdings, fundamental analysis, and fund ratings on the left side of the screen. The right side features IBB's technical analysis chart and long term fund potential. Long term and short term buy ratings indicate our highest possible valuation rating. Click here for additional information on iShares ETF funds or see the ETF research & analysis home page to start.

Portfolio Strategy Update

Be the first to explain iShares Nasdaq Biotechnology (IBB)'s strategy.

Performance Analysis Update